Stonikacidin A, an Antimicrobial 4-Bromopyrrole Alkaloid Containing L-Idonic Acid Core from the Northwestern Pacific Marine Sponge Lissodendoryx papillosa
-
Published:2024-08-30
Issue:9
Volume:22
Page:396
-
ISSN:1660-3397
-
Container-title:Marine Drugs
-
language:en
-
Short-container-title:Marine Drugs
Author:
Tabakmakher Kseniya M.1, Makarieva Tatyana N.1, Sabutski Yuri E.1ORCID, Kokoulin Maxim S.1ORCID, Menshov Alexander S.1ORCID, Popov Roman S.1ORCID, Guzii Alla G.1, Shubina Larisa K.1, Chingizova Ekaterina A.1ORCID, Chingizov Artur R.1, Yurchenko Ekaterina A.1ORCID, Fedorov Sergey N.1, Grebnev Boris B.1, von Amsberg Gunhild23, Dyshlovoy Sergey A.2ORCID, Ivanchina Natalia V.1ORCID, Dmitrenok Pavel S.1ORCID
Affiliation:
1. G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of the Russian Academy of Sciences, Pr. 100-let Vladivostoku 159, 690022 Vladivostok, Russia 2. Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald Tumorzentrum–University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany 3. Martini-Klinik, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, 20251 Hamburg, Germany
Abstract
Stonikacidin A (1), the first representative of a new class of 4-bromopyrrole alkaloids containing an aldonic acid core, was isolated from the marine sponge Lissodendoryx papillosa. The compound is named in honor of Prof. Valentin A. Stonik, who is one of the outstanding investigators in the field of marine natural chemistry. The structure of 1 was determined using NMR, MS analysis, and chemical correlations. The L-idonic acid core was established by the comparison of GC, NMR, MS, and optical rotation data of methyl-pentaacetyl-aldonates obtained from the hydrolysis products of 1 and standard hexoses. The L-form of the idonic acid residue in 1 was confirmed by GC analysis of pentaacetate of (S)-2-butyl ester of the hydrolysis product from 1 and compared with corresponding derivatives of L- and D-idonic acids. The biosynthetic pathway for stonikacidin A (1) was proposed. The alkaloid 1 inhibited the growth of Staphylococcus aureus and Escherichia coli test strains, as well as affected the formation of S. aureus and E. coli biofilms. Compound 1 inhibited the activity of sortase A. Molecular docking data showed that stonikacidin A (1) can bind with sortase A due to the interactions between its bromine atoms and some amino acid residues of the enzyme.
Funder
Russian Science Foundation
Reference69 articles.
1. Marine Natural Products;Carroll;Nat. Prod. Rep.,2024 2. Mahamed, S., Motal, R., Govender, T., Dlamini, N., Khuboni, K., Hadeb, Z., Shaik, B.B., Moodley, K., Mohite, S.B., and Karpoormath, R. (2023). A concise review on marine bromopyrrole alkaloids as anticancer agents. Bioorg. Med. Chem. Lett., 80. 3. Chu, M.-J., Li, M., and Zhao, Y. (2023). Dimeric pyrrole-imidazole alkaloids: Sources, structures, bioactivities and biosynthesis. Bioorg. Chem., 133. 4. Secondary metabolites from marine sponges of the genus Agelas: A comprehensive update insight on structural diversity and bioactivity;Chu;RSC Adv.,2022 5. Chemical and biological diversity of new natural products from marine sponges: A review (2009–2018);Hong;Mar. Life Sci. Technol.,2022
|
|